<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d252" origId="Azathioprine"><sentence id="DrugDDI.d252.s0" origId="s0" text="Use with Allopurinol: The principal pathway for detoxification of azathioprine is inhibited by allopurinol."><entity id="DrugDDI.d252.s0.e0" origId="s0.p1" charOffset="9-20" type="drug" text="Allopurinol"/><entity id="DrugDDI.d252.s0.e1" origId="s0.p5" charOffset="66-78" type="drug" text="azathioprine"/><entity id="DrugDDI.d252.s0.e2" origId="s0.p8" charOffset="95-106" type="drug" text="allopurinol"/><pair id="DrugDDI.d252.s0.p0" e1="DrugDDI.d252.s0.e0" e2="DrugDDI.d252.s0.e1" interaction="false"/><pair id="DrugDDI.d252.s0.p1" e1="DrugDDI.d252.s0.e0" e2="DrugDDI.d252.s0.e2" interaction="false"/><pair id="DrugDDI.d252.s0.p2" e1="DrugDDI.d252.s0.e1" e2="DrugDDI.d252.s0.e2" interaction="true"/></sentence><sentence id="DrugDDI.d252.s1" origId="s1" text="Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose."><entity id="DrugDDI.d252.s1.e0" origId="s1.p11" charOffset="19-31" type="drug" text="azathioprine"/><entity id="DrugDDI.d252.s1.e1" origId="s1.p13" charOffset="36-47" type="drug" text="allopurinol"/><entity id="DrugDDI.d252.s1.e2" origId="s1.p17" charOffset="94-106" type="drug" text="azathioprine"/><pair id="DrugDDI.d252.s1.p0" e1="DrugDDI.d252.s1.e0" e2="DrugDDI.d252.s1.e1" interaction="true"/><pair id="DrugDDI.d252.s1.p1" e1="DrugDDI.d252.s1.e0" e2="DrugDDI.d252.s1.e2" interaction="false"/><pair id="DrugDDI.d252.s1.p2" e1="DrugDDI.d252.s1.e1" e2="DrugDDI.d252.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d252.s2" origId="s2" text="Use with Other Agents Affecting Myelopoesis: Drugs which may affect leukocyte production, including co-trimoxazole, may lead to exaggerated leukopenia, especially in renal transplant recipients."><entity id="DrugDDI.d252.s2.e0" origId="s2.p26" charOffset="45-50" type="drug" text="Drugs"/><entity id="DrugDDI.d252.s2.e1" origId="s2.p32" charOffset="100-114" type="drug" text="co-trimoxazole"/><pair id="DrugDDI.d252.s2.p0" e1="DrugDDI.d252.s2.e0" e2="DrugDDI.d252.s2.e1" interaction="false"/></sentence><sentence id="DrugDDI.d252.s3" origId="s3" text="Use with Angiotensln Converting Enzyme Inhibitors: The use of angiotensin converting enzyme inhibitors to control hypertension in patients on azathioprine has been reported to induce severe leukopenia."><entity id="DrugDDI.d252.s3.e0" origId="s3.p39" charOffset="32-49" type="drug" text="Enzyme Inhibitors"/><entity id="DrugDDI.d252.s3.e1" origId="s3.p42" charOffset="62-91" type="drug" text="angiotensin converting enzyme"/><entity id="DrugDDI.d252.s3.e2" origId="s3.p46" charOffset="142-154" type="drug" text="azathioprine"/><pair id="DrugDDI.d252.s3.p0" e1="DrugDDI.d252.s3.e0" e2="DrugDDI.d252.s3.e1" interaction="false"/><pair id="DrugDDI.d252.s3.p1" e1="DrugDDI.d252.s3.e0" e2="DrugDDI.d252.s3.e2" interaction="false"/><pair id="DrugDDI.d252.s3.p2" e1="DrugDDI.d252.s3.e1" e2="DrugDDI.d252.s3.e2" interaction="true"/></sentence></document>